Neurodevelopment in Children Exposed to Zika in utero: Clinical and Molecular Aspects

Lavínia Schuler-Faccini1,2, Miguel Del Campo3, Alfredo García-Alix4

  • 1Universidade Federal do Rio Grande do Sul, UFRGS, Porto Alegre, Brazil.

Frontiers in Genetics
|March 30, 2022
PubMed

Insights

Congenital Zika syndrome (CZS) causes severe developmental deficits in children. However, milder forms exist, and outcomes vary based on infection timing and cofactors.

Area of Science:

  • Neurology
  • Developmental Biology
  • Infectious Diseases

Background:

  • Zika virus identified as a human teratogen.
  • Congenital Zika syndrome (CZS) presents significant neurodevelopmental challenges.
  • Understanding CZS manifestations and prognosis is crucial.

Purpose of the Study:

  • To review early clinical manifestations of CZS.
  • To analyze factors influencing CZS severity and outcomes.
  • To highlight the spectrum of neurodevelopmental effects.

Main Methods:

  • Literature review of early clinical manifestations of CZS.
  • Analysis of factors affecting vertical transmission and neurodevelopment.
  • Examination of experimental studies on Zika virus outcomes.

Main Results:

  • CZS often leads to severe cerebral palsy and impaired motor, cognitive, and language development.
  • Milder deficits occur, and some non-microcephalic children show normal neurodevelopment.
  • Later pregnancy Zika infections result in less frequent vertical transmission and brain disruption.
  • Cofactors (genetic, environmental, nutritional, social) influence CZS development and distribution.

Conclusions:

  • Congenital Zika syndrome presents a spectrum of neurodevelopmental outcomes.
  • Maternal infection timing and cofactors significantly impact CZS severity.
  • Social determinants affect both CZS prevalence and access to treatment.